Navigation Links
Inhaled Corticosteroids Found To Have No Significant Effect On COPD

COPD or chronic obstructive pulmonary disease is a disease caused by persistent obstruction of the airways // and is associated with severe emphysema or chronic bronchitis. Previous studies have shown inhaled corticosteroids can reduce the mortality rate and number of exacerbations COPD patients experience. However, results from a study conducted by researchers from the University of Washington show otherwise.

Researchers studied more than 2,650 patients with COPD who were prescribed inhaled corticosteroids for at least 80 percent of a 90-day period. Nearly 5,400 patients who had never used inhaled corticosteroids served as the comparing group.

Results of the study show patients who used inhaled corticosteroids did not have a lower mortality rate than patients who did not use the drugs. Researchers also say inhaled corticosteroids had no significant effect on the number of COPD exacerbations or COPD-related hospital stays in the participants. More than 1,000 patients who took part in the study died, and nearly 660 patients were hospitalized for COPD symptoms.

Although results from the study contradict prior research, researchers say the difference in results can be attributed to statistical biases in previous studies.
'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. The Effectiveness Of Inhaled Corticosteroids Studied
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. Inhaled nitric oxide therapy does not reduce death risk of infants
5. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
6. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
7. Inhaled Insulin To Be Made Available in India
8. Inhaled Insulin Could Rock The Drug Market Soon
9. High Cost Forces NHS To Reject Inhaled Insulin
10. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
11. Inhaled Insulin: A New Modality for Management of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... AVIV, Israel , March 27, 2017 ... on oncology and immunology, announced today that AGI-134, an immunotherapy ... announced acquisition of Agalimmune Ltd., will be featured at the ... in Washington, DC to be ... ...
Breaking Medicine Technology: